D
Dariusz Dudek
Researcher at Jagiellonian University Medical College
Publications - 691
Citations - 34241
Dariusz Dudek is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 73, co-authored 646 publications receiving 30298 citations. Previous affiliations of Dariusz Dudek include Imperial College Healthcare & Jagiellonian University.
Papers
More filters
Journal ArticleDOI
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm,Jean-Pierre Bassand,Stefan Agewall,Jeroen J. Bax,Eric Boersma,Héctor Bueno,Pio Caso,Dariusz Dudek,Stephan Gielen,Kurt Huber,Magnus Ohman,Mark C. Petrie,Frank Sonntag,Miguel Sousa Uva,Robert F. Storey,William Wijns,Doron Zahger +16 more
TL;DR: This paper presents a Randomized Assessment of Acute Coronary Syndrome Treatment of Intracoronary Stenting With Antithrombotic Regimen and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction.
Journal ArticleDOI
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf,Jeroen J. Bax,Amadeo Betriu,Carina Blomström-Lundqvist,Filippo Crea,Volkmar Falk,Gerasimos Filippatos,Keith A.A. Fox,Kurt Huber,Adnan Kastrati,Annika Rosengren,P. Gabriel Steg,Marco Tubaro,Freek W.A. Verheugt,Franz Weidinger,Michael Weis,Alec Vahanian,John Camm,Raffaele De Caterina,Veronica Dean,Kenneth Dickstein,Christian Funck-Brentano,Irene Hellemans,Steen Dalby Kristensen,Keith McGregor,Udo Sechtem,Sigmund Silber,Michal Tendera,Petr Widimsky,José Luis Zamorano,Frank V. Aguirre,Nawwar Al-Attar,Eduardo Alegría,Felicita Andreotti,Werner Benzer,Ole A. Breithardt,Nicholas Danchin,Carlo Di Mario,Dariusz Dudek,Dietrich C. Gulba,Sigrun Halvorsen,Philipp A. Kaufmann,Ran Kornowski,Gregory Y.H. Lip,Frans H. Rutten +44 more
TL;DR: Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk/benefit ratio of particular diagnostic or therapeutic means.
Journal ArticleDOI
Bivalirudin during Primary PCI in Acute Myocardial Infarction
Gregg W. Stone,Bernhard Witzenbichler,Giulio Guagliumi,Jan Z. Peruga,Bruce R. Brodie,Dariusz Dudek,Ran Kornowski,Franz Hartmann,Bernard J. Gersh,Stuart J. Pocock,George Dangas,S. Chiu Wong,Ajay J. Kirtane,Helen Parise,Roxana Mehran +14 more
TL;DR: In patients with ST-segment elevation myocardial infarction who are undergoing primary PCI, anticoagulation with bivalirudin alone, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in significantly reduced 30-day rates of major bleeding and net adverse clinical events.
Journal ArticleDOI
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
Antonio Colombo,Janusz Drzewiecki,Adrian P. Banning,Eberhard Grube,Karl Eugen Hauptmann,Sigmund Silber,Dariusz Dudek,Stephen Fort,Francois Schiele,Krysztof Zmudka,Giulio Guagliumi,Mary E. Russell +11 more
TL;DR: Compared with a bare metal stent, paclitaxel-eluting stents reduced in-stent neointimal formation and restenosis and improved 12-month clinical outcome of patients with single de novo coronary lesions.
Journal ArticleDOI
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Bernhard Meier,Bindu Kalesan,Heinrich Mattle,Ahmed A. Khattab,David Hildick-Smith,Dariusz Dudek,Grethe Andersen,Reda Ibrahim,Gerhard Schuler,Antony Walton,Andreas Wahl,Stephan Windecker,Peter Jüni +12 more
TL;DR: Closure of a patent foramen ovale for secondary prevention of cryptogenic embolism did not result in a significant reduction in the risk of recurrent embolic events or death as compared with medical therapy.